Last update 23 Jan 2025

Akron Molecules AG

Overview

Tags

Nervous System Diseases
Immune System Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug3

Related

5
Drugs associated with Akron Molecules AG
AKR-302
Target-
Mechanism-
Active Org.
Akron Molecules AG
Originator Org.
Akron Molecules AG
Active Indication
Anaplastic Large-Cell Lymphoma
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
AKR-101
Target-
Mechanism-
Active Org.
Akron Molecules AG
Originator Org.
Akron Molecules AG
Active Indication
Obesity
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
AKR-210
Target-
Mechanism-
Active Org.
Akron Molecules AG
Originator Org.
Akron Molecules AG
Active Indication
Pain
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Akron Molecules AG
NCT02629146
/ CompletedPhase 4IIT
A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers
NCT02003118
/ CompletedPhase 2
A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain
100 Clinical Results associated with Akron Molecules AG
Login to view more data
0 Patents (Medical) associated with Akron Molecules AG
Login to view more data
100 Deals associated with Akron Molecules AG
Login to view more data
100 Translational Medicine associated with Akron Molecules AG
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 2 Clinical
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
AKR-302
Anaplastic Large-Cell Lymphoma
More
Phase 2
AKR-101
Obesity
More
Preclinical
AKR-210
Pain
More
Preclinical
AKR-202
 ( Purinoceptor )		Pain
More
Pending
AKR-203
 ( Purinoceptor )		Pain
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free